French Cytoo Raises $4.7M in Financing Round Led by Auriga Partners
CYTOO SA., a provider of technologies and products for high content cell analysis, closed its second funding round of $4.7m (approximately €3.2m) led by new investor Auriga Partners.
Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also participate in the investment.
The Grenoble, France-based company will use the funds to grow internationally, expand the team and further its research and development activities.
CYTOO holds an exclusive worldwide license from the Institut Curie and the CNRS (The French national scientific research center) for the adhesive micropattern patent portfolio, as well as license agreements with Harvard University (USA) and CEA, the largest government-funded technological research organization in France.